Loading...
Loading...
ABBV| Name | Value |
|---|---|
| Revenues | 13.9B |
| Cost of Revenue | 6.5B |
| Gross Profit | 7.4B |
| Operating Expense | 5.1B |
| Operating I/L | 2.3B |
| Other Income/Expense | -0.3B |
| Interest Income | 0.2B |
| Pretax | 2.0B |
| Income Tax Expense | 0.2B |
| Net Income/Loss | 1.8B |
AbbVie Inc. is a global pharmaceutical company that specializes in the discovery, development, manufacturing, and sale of a wide range of therapies and medications. The company's product portfolio includes HUMIRA for autoimmune and intestinal Behçet's diseases, SKYRIZI for plaque psoriasis, RINVOQ for rheumatoid arthritis, IMBRUVICA for chronic lymphocytic leukemia, VENCLEXTA for CLL, MAVYRET for chronic HCV infection, and various other medications for conditions such as pancreatic insufficiency, hypothyroidism, irritable bowel syndrome, prostate cancer, endometriosis, Parkinson's disease, glaucoma, and migraine. Additionally, AbbVie offers Botox therapeutic and other eye care products.
